SOAT1 and diffuse large B-cell lymphoma: In a whole exome sequencing and high-throughput second-generation sequencing study of DLBCL patients, a large number of carcinogenic mutations are observed in JAK/STAT signaling pathway, resulting in hyperactive pathway [36].